RBOT Form 4: Director Disposes 2,753 Shares; Post-Sale Holding 40,425

Rhea-AI Filing Summary

Donald F. Tang, a director of Vicarious Surgical Inc. (RBOT), reported an open-market sale of 2,753 shares of Class A common stock on 08/26/2025 at a weighted average price of $6.6965 per share. Following the sale, the filing shows Mr. Tang beneficially owned 40,425 shares. The Form 4 was executed by an attorney-in-fact on 08/27/2025. The filing discloses the weighted average price represents multiple trades that ranged from $6.64 to $7.15 per share, and the reporting person offers to provide trade-specific quantities and prices to SEC staff or the company on request.

Positive

• Timely disclosure of the transaction via Form 4 filed and signed by attorney-in-fact
• Specific price range disclosed ($6.64 to $7.15) with offer to provide trade-level details on request

Negative

• Insider sale reported: 2,753 shares were disposed of on 08/26/2025
• Reduction in beneficial ownership: post-sale holdings are 40,425 shares

Insights

Corporate Governance Expert

TL;DR: Director reported a routine open-market sale and timely Form 4 disclosure; no other governance issues disclosed.

The filing shows a single reported event: an open-market disposition of 2,753 Class A shares by a director, leaving 40,425 shares beneficially owned. The disclosure appears complete for the transaction described and includes a price-range explanation for multiple trades. From a governance perspective, timely reporting and an explicit willingness to provide trade-level details support transparency. The filing does not provide any additional context on intent or related-party arrangements.

Securities Analyst

TL;DR: Insider sale of 2,753 shares at ~$6.70 reported; quantity and price are modest and fully disclosed.

The Form 4 documents an open-market sale executed 08/26/2025 at a weighted average price of $6.6965 per share (trades ranged $6.64–$7.15). Post-transaction beneficial ownership is 40,425 shares. The report is specific about the transaction mechanics and provides contact for further trade-level detail. No derivative or additional transactions are reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tang Donald F

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/26/2025		S		2,753	D	$6.6965(1)	40,425	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This figure is the weighted average sales price of multiple trades ranging from $6.64 to $7.15 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

	/s/ Erin Checka, Attorney-in-Fact	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Donald F. Tang report on Form 4 for RBOT?

The filing reports an open-market sale of 2,753 shares of Class A common stock executed on 08/26/2025.

At what price were the RBOT shares sold by the director?

The weighted average sale price was $6.6965 per share; underlying trades ranged from $6.64 to $7.15 per share.

How many RBOT shares does the reporting person own after the sale?

The Form 4 shows beneficial ownership of 40,425 shares following the reported transaction.

Who signed the Form 4 for this RBOT filing?

The Form 4 was signed by Erin Checka, Attorney-in-Fact on 08/27/2025.

Can I get a breakdown of the number of shares sold at each price?

Yes. The filing states the reporting person will provide SEC staff, Vicarious Surgical Inc., or any security holder with trade-level details on request.